News | November 27, 2025
Investors pile in as Cordance secures oversubscribed seed round for brain-cancer tech
The fresh capital will propel Cordance into its first-in-human clinical trial
The fresh capital will propel Cordance into its first-in-human clinical trial
Subscribe To Our Newsletter & Stay Updated